bibliographic resource 338548 [br/338548]
https://w3id.org/oc/corpus/br/338548

is a

• document
• article

title

• Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer

publication date

• 2013-01-01

contributor

• https://w3id.org/oc/corpus/ar/977458
• https://w3id.org/oc/corpus/ar/977459
• https://w3id.org/oc/corpus/ar/977460
• https://w3id.org/oc/corpus/ar/977461
• https://w3id.org/oc/corpus/ar/977462
• https://w3id.org/oc/corpus/ar/977463
• https://w3id.org/oc/corpus/ar/977464
• https://w3id.org/oc/corpus/ar/977465
• https://w3id.org/oc/corpus/ar/977466
• https://w3id.org/oc/corpus/ar/977467
• https://w3id.org/oc/corpus/ar/977468
• https://w3id.org/oc/corpus/ar/977469
• https://w3id.org/oc/corpus/ar/977470

format

• https://w3id.org/oc/corpus/re/130946

identifier

• https://w3id.org/oc/corpus/id/4688283
• https://w3id.org/oc/corpus/id/503049
• https://w3id.org/oc/corpus/id/503050
• https://w3id.org/oc/corpus/id/503051

part of

• https://w3id.org/oc/corpus/br/80669